Synthesis and biological evaluation of gemcitabine-lipid conjugate (NEO6002).

Bioorg Med Chem Lett

NeoPharm Inc., Research and Development Facility, 1850 Lakeside Drive, Waukegan, IL 60085, USA.

Published: May 2005

A novel gemcitabine-lipid conjugate 5 was synthesized and tested for its in vivo efficacy and toxicity. Compound 5 was tested in BxPC-3 human pancreatic tumor model in SCID mice and exhibited promising activity and lower toxicity when compared with Gemzar.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bmcl.2005.03.046DOI Listing

Publication Analysis

Top Keywords

gemcitabine-lipid conjugate
8
synthesis biological
4
biological evaluation
4
evaluation gemcitabine-lipid
4
conjugate neo6002
4
neo6002 novel
4
novel gemcitabine-lipid
4
conjugate synthesized
4
synthesized tested
4
tested vivo
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!